The Brexit transition period came to an end on 31 December 2020 and as of 1 January 2021 the UK was no longer bound by EU legal framework. Before the UK left the EU, the UK was party to the EU’s regional exhaustion of IP rights regime.
The received wisdom is that company directors can escape liability by sheltering behind the “corporate veil”. But is this true in IP cases?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
What do you do if, before you have obtained a granted patent, a third party starts selling a product that looks like your invention? Is there anything you can do to stop the third party? Does your patent application provide you with any rights before the patent is granted? Parminder Lally and Simon Ambroz answer these questions.
In European patent oppositions, the term “straw person”, is used to describe a person, natural or legal, who files an opposition against a patent on behalf of a third party, with the third party, the real opponent, remaining anonymous throughout the proceedings.
The Greenshoots Podcast by Appleyard Lees, Episode 15: Patent Box – tax relief for patent owners and licensees
Following the release of the 2021/22 UK Budget, corporation tax is set to rise to twenty-five percent in 2023.